Anp will definately get an EU approval for higher does and patient trial definately be a rerate
And with low doses and being effective and no serious adverse side effects.. Higher doses my take will still yield positive results.. But lets see how full read out goes... Will give us a good idea.. Def $2 on the cards easy
Chart, page-695
-
- There are more pages in this discussion • 5,211 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.8¢ |
Change
-0.001(1.27%) |
Mkt cap ! $80.86M | |||
| Open | High | Low | Value | Volume |
| 8.0¢ | 8.0¢ | 7.7¢ | $374.4K | 4.803M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 308385 | 7.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.0¢ | 818650 | 4 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| PER (ASX) Chart |